Working Groups

To ensure the progress of our COST Action, CONNECT has established 5 Working Groups (WGs).

Working Group 1 (WG1)

Pre-clinical research

The main objective of WG1 is to strengthen collaboration on pre-clinical models for kidney disease and brain research. This main objective will be reached by achieving below objectives:

Working Group 2 (WG2)

Clinical research and clinical trials

The main objective of WG2 is to disseminate knowledge on clinical research and clinical trials on cognitive impairment in CKD. Thereby, more, and more successful clinical trials can be conducted on the prevalence, risk factors, and best treatments of MCI-CKD. This main objective will be reached by achieving below objectives:

Working Group 3 (WG3)

Clinical practice

The main objective of WG3 is to strengthen collaborations between nephrologists and neurologists to ensure they speak a common language. When their knowledge is up to date on MCI-CKD, clinicians will be able to cross-diagnose beyond their own expertise and refer patients to neurologists or nephrologists for further diagnosis and treatment when appropriate. This main objective will be reached by achieving below objectives:

Working Group 4 (WG4)

Data management and bioinformatics

The main objective of WG4 is to exchange knowledge on big data management and bioinformatics among researchers for omics, imaging, and epidemiology. This main objective will be reached by achieving below objectives:

Working Group 5 (WG5)

Inclusiveness and dissemination

The main objective of WG5 is to involve diverse stakeholders and disseminate CONNECT Action knowledge to the research and clinical communities. This main objective will be reached by achieving below objectives:

For more details on the Working Groups, see

Know More About CONNECT

View All Members
Discover the Core Group members, the action chairs and WG leaders and Management Committee of the CONNECT COST Action.
To ensure the progress of our COST Action, CONNECT has established 5 Working Groups (WGs).
//